Characteristics | 2021 | 2022 | P value |
---|---|---|---|
Demographics | Â | Â | Â |
 Gender (Male/Female) | 57/38 | 65/37 | 0.591 |
 Age (Mean), years | 65 | 67 | 0.45 |
 BMI (Mean) | 24 | 23 | 0.63 |
 DBP(M ± SD), mmHg | 76.22 ± 9.26 | 75.75 ± 17.74 | 0.09 |
DVT attributes | Â | Â | Â |
 Type of DVT |  |  |  |
 Unilateral distal  Unilateral proximal  Bilateral distal  Bilateral proximal | 36(37.9%) 26(27.4%) 23(24.2%) 10(10.5%) | 43(42.2%) 25(24.5%) 25(24.5%) 9(8.8%) | 0.528 |
 Risk grade of DVT |  |  |  |
 0 grade  1 grade  2 grade | 4(4.2%) 57(60%) 34(35.8%) | 3(2.9%) 53(52%) 46(45.1%) | 0.398 |
 PE |  |  |  |
 None  Periphery  Central | 59(62.1%) 7(7.4%) 29(30.5%) | 60(58.8%) 8(7.8%) 34(33.4%) | 0.894 |
Median follow up (Range), days | 124 (96–421) | 116.5 (91–446) | < 0.0001 |
 Hemorrhage events |  |  |  |
 None  Minor  Major | 79 15 1 | 91 10 1 | 0.199 |
 Therapeutic outcomes |  |  |  |
 Stable condition  Remission  Aggravation | 23(24.2%) 53(55.8%) 19(20%) | 33(32.3%) 34(33.3%) 35(34.3%) | 0.005 |
Clinical characteristics | Â | Â | Â |
 Diagnosis |  |  | 0.319 |
  Advanced lung cancer (SCC/adenocarcinoma/SCLC) | 10/33/4 | 10/34/5 |  |
  Postoperative | 10 | 11 | |
  Benign lung diseases (None/Interstitial lung disease/Tuberculosis/ COPD/Pneumonia/Bronchiectasis/PAH) | 2/4/8/3/13/6/2 | 7/5/5/10/5/6/4 | |
 Ongoing treatment |  |  | 0.197 |
  Antitumor | 47(49.5%) | 57(55.9%) |  |
  HREZ   anti-infection   hemostasis   None | 8(8.4%) 23(24.2%) 4(4.2%) 13(13.7%) | 5(4.9%) 14(13.7%) 5(4.9%) 21(20.6%) | |
 Time from active ongoing treatment to DVT confirmed, months (< 6/6–12/>12) | 83/9/3 | 83/7/12 | 0.067 |
 COVID-19(None/Previously diagnosed within 6 months) | 88/7 | 43/59 | < 0.001 |
Relevant blood biochemistry tests | Â | Â | Â |
 RBC (< 4.3*1012/L / >4.3*1012/L) | 56/39 | 60/42 | 1 |
 WBC (< 9.5*1012/L / >9.5*1012/L) | 72/23 | 79/23 | 0.867 |
 PLT (< 125*109/L / >125*109/L) | 8/87 | 22/80 | 0.016 |
 ALT (< 49IU/L / >49IU/L) | 81/14 | 92/10 | 0.29 |
 CRE (< 97umol/L / >97umol/L) | 91/4 | 93/9 | 0.2 |
 D-dimer level ( Decreased / Increased ) | 66/29 | 67/35 | 0.571 |
 PT (< 11s / >11s) | 18/77 | 27/75 | 0.237 |